T cells

December 7, 2018

Generon Set to Begin Phase 1 Trial of A-319 in Patients With B-cell Cancers in China

News

China’s regulatory agency has approved the launch of Generon‘s Phase 1 clinical trial to test its immunotherapy candidate, A-319, in patients with acute lymphoblastic leukemia (ALL) and B-cell lymphoma. Approval of ... Read more

October 24, 2018

Leukemia and Lymphoma Society Grants $5M for Development of Blood Cancer Immunotherapies

News

A team of Texas researchers received a grant of $5 million from the Leukemia and Lymphoma Society to develop targeted immunotherapies for blood cancers. The Specialized Center of Research (SCOR) grant will provide ... Read more

April 10, 2017

Variety of T-cells Linked to Better Survival in Non-Hodgkin’s Lymphoma, Study Shows

News

Patients with non-Hodgkin’s lymphoma show better chances of survival if they have a diverse variety of T-cells, are diverse, according to recent research from the University of Queensland, Australia. These ... Read more

January 6, 2017

Proteins Mutated in Lymphoma Control Normal T-cell Development, Study Finds

News

Proteins that are often mutated in T-cell lymphomas are crucial for normal T-cell development, researchers have discovered. Mice lacking the factors developed an abnormal T-cell type that gave rise to ... Read more

January 5, 2017

Study Links 2 Inherited Mutations to Risk of Cutaneous T-Cell Lymphoma

News

Mutations in two genes coding for the immune cytokines IL-2 and IL-13 increase the risk of cutaneous T-cell lymphoma (CTCL), researchers have found, while mutations in two other immune factors ... Read more

December 2, 2016December 2, 2016

Adaptive to Discuss Test to Detect ‘Minimal Residual’ Lymphoid Cancer at ASH Meeting

News

Adaptive Biotechnologies will present data showing the clinical validity and prognostic value of its clonoSEQ Assay to detect minimal residual disease in people with lymphoid cancers. The presentations will take place at ... Read more

November 28, 2016

New and Future Treatments for Lymphoma

In this video from the Lymphoma Association, Dr. Graham Collins, consultant hematologist from the Oxford Cancer and Haemotology Centre; and Dr. Andrew McMillan and Dr. Christopher Fox, consultant hematologists from the ... Read more

November 10, 2016November 10, 2016

Defects in Molecular Controls for Key Immune Cell May Be Behind Onset of Blood Cancers

News

Immune cells triggered to fight an infection have two distinct and controlling internal clocks — one determines the amount of time such a cell has to divide, and the other determines how long the ... Read more

November 8, 2016

Trial Data on Kite’s Lead Candidate for B-Cell Lymphomas to Be Presented at Meeting

News

Kite Pharma will present data from multiple clinical trials of KTE-C19, the company’s lead candidate CAR-T cell therapy for B-cell lymphomas and leukemias at the American Society of Hematology (ASH) ... Read more

September 6, 2016September 6, 2016

Stem Cell Transplants to Treat Blood Cancers May Cause Immune Cells to Age as Much as 30 Years

News

Cancer treatments are known to have several side effects in patients, such as fatigue, nausea, and hair loss. Now, a study suggests that stem cell transplants may induce the premature aging ... Read more